Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Mls presentation by peritoneal cavity B cells.

James E Riggs1, Koko F Howell, Justin Taylor

  • 1Department of Biology, Rider University, 2083 Lawrenceville Road, Lawrenceville, NJ 08648-3099, USA. riggs@rider.edu

Immunobiology
|November 3, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Real-world, multi-omics validation of the clinical relevance of molecular taxonomy for myelodysplastic syndromes (MDS).

HemaSphere·2026
Same author

Targeted Connectomic Neuromodulation of the Orbitofrontal Cortex To Treat Obsessive-Compulsive Disorder.

medRxiv : the preprint server for health sciences·2026
Same author

Targeting an RNA Editor to Impede H3K27M+ Pediatric Gliomas.

bioRxiv : the preprint server for biology·2026
Same author

Remibrutinib (Rhapsido) for chronic spontaneous urticaria.

Trends in pharmacological sciences·2026
Same author

CIPHER-seq enables intracellular multimodal profiling of cytokine responses in single immune cells.

Scientific reports·2026
Same author

Surgical Management of Wrist Arthritis Is Linked to Increased Carpal Tunnel Syndrome/Carpal Tunnel Release Risk: Rethinking Preoperative Evaluation.

The Journal of hand surgery·2026
Same journal

ST2-mediated ERK/JNK/P38/NF-κB signaling: a target of Biminkang mixture in minimal persistent inflammation of allergic rhinitis.

Immunobiology·2026
Same journal

Chronic stress promotes colorectal cancer progression by inducing M2 macrophage polarization and activating the CCL2-CCR2 axis.

Immunobiology·2026
Same journal

Spatial-cellular resolution analysis of ferroptosis-associated immune microenvironment heterogeneity in osteoarthritic cartilage.

Immunobiology·2026
Same journal

Exploring therapeutic targets for neuroinflammation in sepsis-associated encephalopathy: a combined network pharmacology and bioinformatics approach.

Immunobiology·2026
Same journal

Potential correlation assessment identified by a genome-wide association study using induced pluripotent stem cells from patients with IgAN.

Immunobiology·2026
Same journal

MicroRNA-5011-5p attenuates LPS-induced inflammatory damage in periodontal ligament cells by targeting KLF6: an in vitro study.

Immunobiology·2026
See all related articles

Peritoneal cells present Mls-1a superantigen less effectively than spleen cells in vitro, despite containing both B cells and suppressors. B-1 cells are less effective presenters than B-2 cells.

Area of Science:

  • Immunology
  • Cell Biology

Background:

  • The minor lymphocyte stimulatory (Mls) superantigens play a role in T cell activation and immune responses.
  • Understanding antigen-presenting cell (APC) function in different anatomical locations is crucial for immunology.

Purpose of the Study:

  • To compare the in vitro antigen-presenting capacity of spleen cells versus peritoneal cells for the Mls-1a superantigen.
  • To investigate the role of B cell subsets and other peritoneal cells in Mls-1a presentation and T cell response modulation.

Main Methods:

  • DBA/2J mice spleen and peritoneal cells were isolated.
  • Cells were compared for their ability to present Mls-1a to T cells in vitro.
  • Flow cytometry was used to analyze B cell surface markers.
  • B cell subsets (B-1 and B-2) were isolated using cell sorting.

Related Experiment Videos

  • Mixing experiments were conducted to assess presentation and suppression.

    • Main Results:

    • Peritoneal cells were less effective than spleen cells at presenting Mls-1a in vitro.
    • No significant differences in T cell interaction markers were found between spleen and peritoneal B cells.
    • Peritoneal B-1 cells were capable of Mls-1a presentation but less effective than B-2 cells.
    • Total peritoneal cells exhibited an inhibitory effect on T cell responses to Mls-1a presented by spleen cells.

    Conclusions:

    • The peritoneal cavity contains B cells that can present Mls-1a, but their efficacy differs by subset (B-2 > B-1).
    • The peritoneal cavity also harbors non-B cells that can suppress T cell responses to Mls-1a.
    • These findings highlight a complex interplay of antigen presentation and suppression within the peritoneal environment.